Send the work, get clean data back

The front door for science

Start with whatever you have: a sequence, a structure, or just the question you need answered. We find the right lab from our global directory, get the best price, check every result, and send back clean data.

For emerging biotechs · AI x bio teams · virtual companies with no wet lab · discovery groups short on capacity · academic labs

Built by a world-class team from

Mount SinaiHarvard Medical SchoolStanford UniversityBill & Melinda Gates FoundationMetaTeslaPathAIRoivant Sciences

One request in, clean data out

We do the searching, the bidding and the checking. You approve the lab, the scope and the price, and you get the raw data to check for yourself.

01

You send the study

The question you need answered, your sequences or structures as FASTA or CSV, and your timing. A draft is enough to start.

02

Labs compete

We route it to every lab we have audited and trust, matched on scientific fit and current capacity. They bid on the same scope, and the price falls to the floor.

03

You approve

Review the lab, study scope, milestones, quality plan, deliverables, and final price before anything starts.

04

You get clean data

We coordinate the work, track milestones, surface issues early, check every result, and return clean data with the raw data behind it.

86 measurements across 8 modalities, and growing

Knockdown + cytotoxOligoDuplex TmOligoIsoform / allele selectivityOligoHepatotoxicity screenOligoOff-target transcriptomicsOligoBinding (FP)PeptideSolubility & aggregationPeptideSelectivity panelPeptideSGF / SIF stabilityPeptideImmunogenicityPeptideThermostabilityProteinEndotoxinProteinDLSProteinSpecific activityEnzymeSubstrate scope panelEnzymeInhibitionEnzymeSEC oligomeric stateEnzymeDevelopability bundleVHHSpecies cross-reactivityVHHBlocking / neutralizationVHHEffector functionVHHCell panel expressionmRNAIn vivo expressionmRNAThermal + freeze-thaw stabilityAAV capsidNAb assayAAV capsidSafety coreSmall moleculeBlood-to-plasma + plasma stabilitySmall moleculeEarly tox triadSmall moleculeKinase selectivitySmall molecule
Dose-responseOligoProtein-level knockdownOligoInnate immune activationOligoGymnotic vs transfected uptakeOligoMouse liver knockdownOligoProtease + plasma stabilityPeptideCircular dichroismPeptideCAPA permeabilityPeptideLogDPeptideMouse PKPeptideSECProteinEpitope binningProteinSerum stabilityProteinKineticsEnzymeTmEnzymeOperational stabilityEnzymeProduct inhibitionEnzymeCell bindingVHHPolyspecificityVHHAccelerated stabilityVHHExpressionmRNAStabilitymRNATransductionAAV capsidAggregationAAV capsidPooled in vivo biodistributionAAV capsidPotencySmall moleculeLogD, pKa, thermodynamic solubilitySmall moleculeMouse cassette PKSmall moleculeLate-preclinical setSmall molecule
Nuclease stabilityOligoKnockdown kinetics & durationOligoComplement activationOligoCell panelOligoBinding (SPR / BLI)PeptidePermeabilityPeptideFunctional cell assayPeptideMicrosomal stabilityPeptideHemolysis + cytotoxicityPeptideBindingProteinIntact massProteinFunctional blockingProteinFreeze-thawProteinRobustnessEnzymeEnantio- / regioselectivityEnzymeCofactor / metal dependenceEnzymeAffinityVHHIntact mass + endotoxinVHHAC-SINSVHHFcRn bindingVHHExpression kineticsmRNALNP biophysicsmRNAFull / empty ratioAAV capsidResidual host DNA / plasmidAAV capsidADME coreSmall moleculeHepatocyte stabilitySmall moleculeP-gp / BCRP substrateSmall moleculeOff-target panelSmall molecule

Core products

You bring a batch of designs or an unanswered question. We take it from there and hand back data you can act on.

01Protein & antibody validation

Test more designs per round

VHHs, scFvs, Fabs, miniproteins and peptides · from a binder call through full kinetics and developability

Send sequences, not samples. Versioned protocols and defined controls keep every round comparable to the last.

Sent
Sequences as FASTA or CSV, 24 to 768 per batch
Run
Expression, binding affinity, thermostability, developability
Back
Structured results with the raw instrument files

24 to 768 designs per batch. Pricing and turnaround on the next page.

02Small molecule synthesis & profiling

Make it, then measure it

SMILES in, characterized compounds out · make-on-demand synthesis, then ADME, potency, stability and early tox

Send structures. We build from stocked blocks in two or three steps, then run the readouts that decide what to carry forward.

Sent
Structures as SMILES, ranked or scored
Run
Synthesis and QC, then ADME core, potency, stability, cassette PK
Back
Purity and identity per compound, with the ADME and PK data

Scoped per campaign. Bespoke routes quoted separately.

03China IIT advisory

Reach clinical signal sooner

Oncology, cell and gene therapy, selected rare disease · investigators and institutions across major China trial centers

We find the investigator, diligence the operating team, and stay accountable from ethics submission through data delivery.

Sent
The development question and a draft protocol concept
Run
Investigator selection, ethics submission, site setup, oversight
Back
Efficacy readout with agreed data access and transfer terms

Scoped per study, fee quoted before we start.

Speed to the next milestone

Running an experiment should be as easy as starting to build software. We make it fast, cheap, and high quality, instead of making you choose between them.

01

Start sooner

No RFP round. Your protocol goes straight to labs we have already audited, with capacity confirmed, so the study starts in days instead of after weeks of chasing quotes.

02

Trust the data

We check every result, and can resample a slice against a gold-standard lab. You get raw data alongside the summary, so nothing in your program rests on a report you cannot verify.

03

Pay less

Labs bid against each other on the same scope, so the price falls to the floor instead of to whatever the first quote happened to say. You see it before you commit.

Built for teams without a lab to spare

Different reasons for needing work run, same problem underneath: the science is ready before the capacity is.

AI x bio teams

You design faster than you can test

Rounds of designs pile up waiting on wet-lab capacity. We run batches against versioned protocols so results are comparable round to round and clean enough to train on.

Validate a batch
Virtual and emerging biotechs

You have programs but no bench

No lease, no instruments, no vendor management headcount. We become the execution layer, and stay accountable for scope, timeline, and data quality.

Talk through a program
Discovery groups at capacity

Your bench is already full

Overflow and triage work without adding equipment or headcount. Send the studies that are queued behind everything else and keep your own team on the critical path.

Offload a study
Clinical-stage teams

You need a human signal sooner

An early read before committing to a full global path. We identify investigators and institutions in China, diligence the operating team, and manage setup through data delivery.

Discuss an IIT

What we commit to on every study

Four promises that hold whatever the study is, and that you can hold us to.

A row of assorted tablets and capsules on a navy to cyan gradient
  1. 01

    The lowest price we can find

    Every study goes out to competing bids across the network, so the price falls to the floor instead of landing wherever the first quote happened to sit. You see what we found. If you are quoted less elsewhere for the same scope, tell us and we will match it or explain exactly why we cannot.

  2. 02

    The price you approve is the price you pay

    Scope, timeline and cost are agreed before any work starts. Nothing changes without your sign-off, and you see the lab cost and our fee separately rather than bundled into one number.

  3. 03

    We check the work before you see it

    Every result is reviewed against the agreed controls and acceptance criteria, and a slice can be resampled against a gold-standard lab. Anything that fails is flagged and rerun, not quietly reported.

  4. 04

    The raw data is yours

    You get the underlying instrument files with every result, not just a summary you have to take on faith. Data rights and transfer terms are settled at the outset.

Start your next study

Send the study, the development question, or the bottleneck. We will review it and come back with a practical next step.

FAQ

Can you work from an existing protocol?

Yes. We can source directly against your protocol or help translate a development question into a workable scope. We will flag where methods, controls, or deliverables need clarification before quoting.

How do you pick the lab?

Every lab in the network is audited before it can bid: scientific experience, operating team, facilities, quality systems, and data practices. Once your spec is in, the qualified labs compete on the same scope and you see the winner, the price, and the timeline before committing.

How do I know the data is good?

Controls, acceptance criteria, and deliverables are set before kickoff. We check every result as it comes back, and can resample a slice against a gold-standard lab so the numbers are verified independently rather than taken on trust. You always get the raw data alongside the summary.

How is pricing structured?

Labs bid against each other on the same scope, so you are not anchored to whichever quote arrived first. You see the lab cost, our fee, the assumptions, and the change terms before work begins.

How much do I have to manage?

Nothing, unless you want to. We are the single interface through delivery: we coordinate the lab, track milestones, review changes against scope, escalate risks, and flag anything that could affect timing or data quality. You never talk to the vendor.

How is this different from a CRO or a marketplace?

A CRO sells you its own capacity, so every study has to fit what that one shop happens to do well, at its price. A marketplace charges for access to a directory and then leaves you to run the vendor yourself. We sit in the middle: many audited labs competing on your scope, one interface, and quality control on the results. For preclinical work that means selecting the right model, assay, and operating team; for clinical work our current focus is China IITs. You get the reach of a marketplace with someone accountable for the data.

Search the network

Explore preclinical and clinical providers by capability and location, or ask Arborworks to run the search for your study. Capabilities include screening, pharmacology, toxicology, bioanalysis, clinical operations, biomarkers, imaging, and specialized scientific services.